ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study

Mendelian analysis of ACE serum concentrations of 4,147 participants of the ORIGIN trial predicated that genetically lower ACE concentrations were associated with a lower risk of type 2 diabetes (OR per standard deviation = 0.92, 95% CI 0.89-0.95).

Source:

Diabetes Care